CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Long-Lived Assets
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Long-Lived Assets of $1.49 billion as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Segment Reporting
us-gaap:NoncurrentAssets · last filed 2026-08-05
- 2026-06-27: Long-Lived Assets $1.49B.
- 2026-03-28: Long-Lived Assets $1.51B.
- 2025-12-27: Long-Lived Assets $1.66B.
- 2025-09-27: Long-Lived Assets $1.59B.
| Period end | Long-Lived Assets |
|---|---|
| 2026-06-27 | $1.49B 10-Q · filed 2026-08-05 |
| 2026-03-28 | $1.51B 10-Q · filed 2026-05-07 |
| 2025-12-27 | $1.66B 10-Q · filed 2026-08-05 |
| 2025-09-27 | $1.59B 10-Q · filed 2025-11-05 |
| 2025-06-28 | $1.61B 10-Q · filed 2025-08-06 |
| 2025-03-29 | $1.59B 10-Q · filed 2025-05-07 |
| 2024-12-28 | $1.60B 10-K · filed 2026-02-18 |
| 2024-09-28 | $1.64B 10-Q · filed 2024-11-06 |
| 2024-06-29 | $1.61B 10-Q · filed 2024-08-07 |
| 2024-03-30 | $1.62B 10-Q · filed 2024-05-09 |
| 2023-12-30 | $1.64B 10-K · filed 2026-02-18 |
| 2022-12-31 | $1.47B 10-K · filed 2025-02-19 |
| 2021-12-25 | $1.29B 10-K · filed 2024-02-14 |
| 2020-12-26 | $1.12B 10-K · filed 2023-02-22 |
| 2019-12-28 | $1.04B 10-K · filed 2022-02-16 |
| 2018-12-29 | $932.88M 10-K · filed 2021-02-17 |
| 2017-12-30 | $781.97M 10-K · filed 2020-02-11 |
| 2016-12-31 | $755.83M 10-K · filed 2019-02-13 |
| 2015-12-26 | $677.96M 10-K · filed 2018-02-13 |
| 2014-12-27 | $676.80M 10-K · filed 2017-02-14 |
| 2013-12-28 | $738.15M 10-K · filed 2016-02-12 |
| 2012-12-29 | $765.68M 10-K · filed 2015-02-17 |
| 2011-12-31 | $795.69M 10-K · filed 2014-02-25 |
| 2010-12-25 | $814.98M 10-K · filed 2013-02-27 |
| 2009-12-26 | $916.92M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |